HRMY

Harmony Biosciences Holdings, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-24

Figures on this page computed 2026-11-08 12:32 UTC

Last close

34.42USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-02-24

12.0xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001104659-26-018859
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-24
The filing itself
53.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001104659-26-018859
Reported in
USD
- 10-K for 2025, filed 2026-02-24
- 10-K for 2025, filed 2026-02-24
- 10-K for 2025, filed 2026-02-24
- 10-Q for 2025, filed 2026-11-04
- 10-K for 2025, filed 2026-02-24
- 10-Q for 2025, filed 2026-11-04
The filing itself
18.3%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001104659-26-018859
Reported in
USD
- 10-K for 2025, filed 2026-02-24
- 10-K for 2025, filed 2026-02-24
The filing itself
40.1%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001104659-26-018859
Reported in
USD
- 10-K for 2025, filed 2026-02-24
- 10-K for 2025, filed 2026-02-24
The filing itself
0.19Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001104659-26-018859
Reported in
USD
- 10-K for 2025, filed 2026-02-24
- 10-Q for 2025, filed 2026-11-04
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

What it sells, to whom

lens 8 of 9

What it sells

1

Rare Neurological Diseases Segment868,453,000 UNIT_STAND100%

Where it sells it

1

United States500,000,000 USD100%

Each band is a share of itself. A segment and a place are two cuts of the same revenue, so they are never added together.

1 segments, 1 places and 0 named customers, each as the filer published it.

1 segments, 1 places and 0 named customers, each as the filer published it.

Every figure in this lens

Rare Neurological Diseases Segment868,453,00010-K for 2025, filed 2026-02-24
Source
filed
Statement
segments
Fiscal year
2025
Accession
0001104659-26-018859
Reported in
UNIT_STAND
The filing itself
United States500,000,00010-K for 2023, filed 2024-02-22
Source
filed
Statement
revenue_mix
Fiscal year
2023
Accession
0001558370-24-001466
Reported in
USD
The filing itself